Q1 2023 Therapeutic mRNA Patent Monitor Report: Uncovering Current Dynamics in mRNA Design & Delivery
SOPHIA ANTIPOLIS, France – April 21, 2023 │ The quarterly report for the Q1 2023 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. Let’s focus on current dynamics in mRNA design & delivery. Q1 2023: Exploring the dynamic activity of[…]